Cargando…

A deep neural network approach to predicting clinical outcomes of neuroblastoma patients

BACKGROUND: The availability of high-throughput omics datasets from large patient cohorts has allowed the development of methods that aim at predicting patient clinical outcomes, such as survival and disease recurrence. Such methods are also important to better understand the biological mechanisms u...

Descripción completa

Detalles Bibliográficos
Autores principales: Tranchevent, Léon-Charles, Azuaje, Francisco, Rajapakse, Jagath C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6923884/
https://www.ncbi.nlm.nih.gov/pubmed/31856829
http://dx.doi.org/10.1186/s12920-019-0628-y
_version_ 1783481613560053760
author Tranchevent, Léon-Charles
Azuaje, Francisco
Rajapakse, Jagath C.
author_facet Tranchevent, Léon-Charles
Azuaje, Francisco
Rajapakse, Jagath C.
author_sort Tranchevent, Léon-Charles
collection PubMed
description BACKGROUND: The availability of high-throughput omics datasets from large patient cohorts has allowed the development of methods that aim at predicting patient clinical outcomes, such as survival and disease recurrence. Such methods are also important to better understand the biological mechanisms underlying disease etiology and development, as well as treatment responses. Recently, different predictive models, relying on distinct algorithms (including Support Vector Machines and Random Forests) have been investigated. In this context, deep learning strategies are of special interest due to their demonstrated superior performance over a wide range of problems and datasets. One of the main challenges of such strategies is the “small n large p” problem. Indeed, omics datasets typically consist of small numbers of samples and large numbers of features relative to typical deep learning datasets. Neural networks usually tackle this problem through feature selection or by including additional constraints during the learning process. METHODS: We propose to tackle this problem with a novel strategy that relies on a graph-based method for feature extraction, coupled with a deep neural network for clinical outcome prediction. The omics data are first represented as graphs whose nodes represent patients, and edges represent correlations between the patients’ omics profiles. Topological features, such as centralities, are then extracted from these graphs for every node. Lastly, these features are used as input to train and test various classifiers. RESULTS: We apply this strategy to four neuroblastoma datasets and observe that models based on neural networks are more accurate than state of the art models (DNN: 85%-87%, SVM/RF: 75%-82%). We explore how different parameters and configurations are selected in order to overcome the effects of the small data problem as well as the curse of dimensionality. CONCLUSIONS: Our results indicate that the deep neural networks capture complex features in the data that help predicting patient clinical outcomes.
format Online
Article
Text
id pubmed-6923884
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-69238842019-12-30 A deep neural network approach to predicting clinical outcomes of neuroblastoma patients Tranchevent, Léon-Charles Azuaje, Francisco Rajapakse, Jagath C. BMC Med Genomics Research BACKGROUND: The availability of high-throughput omics datasets from large patient cohorts has allowed the development of methods that aim at predicting patient clinical outcomes, such as survival and disease recurrence. Such methods are also important to better understand the biological mechanisms underlying disease etiology and development, as well as treatment responses. Recently, different predictive models, relying on distinct algorithms (including Support Vector Machines and Random Forests) have been investigated. In this context, deep learning strategies are of special interest due to their demonstrated superior performance over a wide range of problems and datasets. One of the main challenges of such strategies is the “small n large p” problem. Indeed, omics datasets typically consist of small numbers of samples and large numbers of features relative to typical deep learning datasets. Neural networks usually tackle this problem through feature selection or by including additional constraints during the learning process. METHODS: We propose to tackle this problem with a novel strategy that relies on a graph-based method for feature extraction, coupled with a deep neural network for clinical outcome prediction. The omics data are first represented as graphs whose nodes represent patients, and edges represent correlations between the patients’ omics profiles. Topological features, such as centralities, are then extracted from these graphs for every node. Lastly, these features are used as input to train and test various classifiers. RESULTS: We apply this strategy to four neuroblastoma datasets and observe that models based on neural networks are more accurate than state of the art models (DNN: 85%-87%, SVM/RF: 75%-82%). We explore how different parameters and configurations are selected in order to overcome the effects of the small data problem as well as the curse of dimensionality. CONCLUSIONS: Our results indicate that the deep neural networks capture complex features in the data that help predicting patient clinical outcomes. BioMed Central 2019-12-20 /pmc/articles/PMC6923884/ /pubmed/31856829 http://dx.doi.org/10.1186/s12920-019-0628-y Text en © The Author(s) 2019 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Tranchevent, Léon-Charles
Azuaje, Francisco
Rajapakse, Jagath C.
A deep neural network approach to predicting clinical outcomes of neuroblastoma patients
title A deep neural network approach to predicting clinical outcomes of neuroblastoma patients
title_full A deep neural network approach to predicting clinical outcomes of neuroblastoma patients
title_fullStr A deep neural network approach to predicting clinical outcomes of neuroblastoma patients
title_full_unstemmed A deep neural network approach to predicting clinical outcomes of neuroblastoma patients
title_short A deep neural network approach to predicting clinical outcomes of neuroblastoma patients
title_sort deep neural network approach to predicting clinical outcomes of neuroblastoma patients
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6923884/
https://www.ncbi.nlm.nih.gov/pubmed/31856829
http://dx.doi.org/10.1186/s12920-019-0628-y
work_keys_str_mv AT trancheventleoncharles adeepneuralnetworkapproachtopredictingclinicaloutcomesofneuroblastomapatients
AT azuajefrancisco adeepneuralnetworkapproachtopredictingclinicaloutcomesofneuroblastomapatients
AT rajapaksejagathc adeepneuralnetworkapproachtopredictingclinicaloutcomesofneuroblastomapatients
AT trancheventleoncharles deepneuralnetworkapproachtopredictingclinicaloutcomesofneuroblastomapatients
AT azuajefrancisco deepneuralnetworkapproachtopredictingclinicaloutcomesofneuroblastomapatients
AT rajapaksejagathc deepneuralnetworkapproachtopredictingclinicaloutcomesofneuroblastomapatients